Overview
The Therapeutic Aspects of CytoSorb Therapy
Helping doctors and healthcare professionals regain control by restoring the balance.
Here, you can find more information on CytoSorb Therapy as applied to your areas of specialization. This section includes specifics on patient selection, timing, dosing, and all available research.

Proven safety
Over 250,000 hemoadsorption treatments over the last ten years.
Most peer-reviewed adsorber
Over 1,100 publications, abstracts, posters, manuscripts, and other resources.
Improved patient outcomes
With demonstrated efficacy across cardiovascular, hepatic, hepatic, and critical care.
Simple system integration
Starting patient treatment with CytoSorb technology is fast and easy, with less work for nurses, and greater peace of mind.
Proprietary bead technology
Each CytoSorb cartridge features ISO 10993-certified porous polymer beads, for biocompatibility and hemocompatibility.
Concentration-dependent and size-dependent removal
Effective removal of cytokines, bilirubin, myoglobin, rivaroxaban, and ticagrelor—and minimal removal of important substances such as albumin.
Voices around the world

Dr. Yatin Mehta
India, GurgaonCytoSorb is indicated for use in conditions where elevated levels of cytokine and/or bilirubin and/or myoglobin exist.
Access Healthcare Professionals Area
This area is for Health Care Professionals only and provides reports about clinical experiences gained during the use of CytoSorbents products. The information presented reflects the opinions and procedural techniques of individual physicians and is not intended as medical advice. Physician experience, risks, patient outcomes and results may vary. This content is intended for Health Care Professionals outside the United States and Canada as CytoSorb has not yet been approved or cleared in the United States or Canada for any indication, except under an Emergency Use Authorization (EUA) by the US FDA.